Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00560781 · ClinicalTrials.gov registry record · NA
Targeting Cognition in PTSD: Pregnenolone Augmentation of SSRIs
A NA study, sponsored by Durham VA Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 27
- Enrollment target
NCT00560781 is a NA study that has completed, run by Durham VA Medical Center. The registered enrollment target is 27 participants.
The verdict
NCT00560781, a NA study, has completed, sponsored by Durham VA Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 27 participants
- Enrollment target
Study Summary
This study will test the therapeutic potential of augmenting a stable SSRI regimen with the neurosteroid pregnenolone to reduce cognitive symptoms and PTSD symptoms in patients diagnosed with PTSD.
Interventions
- DRUG Pregnenolone or Placebo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 27 participants |
| Start Date | 2006-04 |
| Est. Completion | 2007-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00560781
The ClinicalTrials.gov registry entry for NCT00560781 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 27 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Durham VA Medical Center, which has 17 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Pregnenolone or Placebo is the first listed.
NCT00560781 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00560781 about?
NCT00560781 is a clinical study titled "Targeting Cognition in PTSD: Pregnenolone Augmentation of SSRIs". This study will test the therapeutic potential of augmenting a stable SSRI regimen with the neurosteroid pregnenolone to reduce cognitive symptoms and PTSD symptoms in patients diagnosed with PTSD.
What is the current status of trial NCT00560781?
This trial is currently completed. It is a NA study. The enrollment target is 27 participants. The study started on 2006-04. Estimated completion is 2007-05.
What interventions are being tested in trial NCT00560781?
The interventions under investigation include: Pregnenolone or Placebo (DRUG).
Who is sponsoring clinical trial NCT00560781?
This trial is sponsored by Durham VA Medical Center, which has 17 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.